Medical Devices & Tech

Vivostat A/S

Borupvang 2 / DK-3450
, Denmark
Phone
Fax
Click for website

Research Sector Medical Devices & Tech

Summary Description The Vivostat system is the worlds-only automated system for the on-site preparation and application of fibrin sealant or Platelet Rich Fibrin (PRF) from the patients own blood.

Management Tom Bjerg Lauritzen (President & CEO); Martin M Poulsen (VP of Marketing); Anne Klitg?rd (VP of Regulatory and Medical Affairs); Henrik Vester-Andersen (VP of Sales)

Click here for Financial Data
Keywords: Autologus fibrin sealant, surgical sealant, wound healing, growth factors, haemostats

Comment


Updated: Apr. 18, 2011


Description

Vivostat A/S is a privately owned company based in the Medicon Valley of Scandinavia. The company focuses on development, manufacturing and marketing of a range of medical devices all based on the uni......view more

Products / Services

The advanced Vivostat technology is used on a daily basis in a great number of surgical departments and wound care centres across Europe and Asia. Today, three products are available, all based on the......view more

Technology / Differentiation

The Vivostat technology utilizes the patient's own blood to derive either a surgical sealant to prevent/stop bleedings, or a gel with a high concentration of growth factors (Platelet Rich Fibrin) that...view more

Market / Customers

The world-wide market for surgical sealants is estimated to be around USD 700-800 million with an annual growth of 10-16% (depending on the region). No market reports describing the world-wide mar......view more


Status

Vivostat A/S recently started the US approval process for Vivostat PRF. Furthermore, in 2007 Vivostat A/S has established direct sales organizations in the major European markets, Germany and the UK....view more

RELATED COMPANIES